Why ALT Alone is Elevated to 87 U/L
An isolated ALT elevation to 87 U/L (approximately 2× the upper limit of normal) most commonly indicates mild hepatocellular injury, with non-alcoholic fatty liver disease (NAFLD), alcohol-related liver disease, and chronic viral hepatitis being the predominant causes in clinical practice 1.
Understanding the Clinical Significance
The magnitude of ALT elevation matters less than you might think. An ALT of 87 U/L does not predict severity or prognosis—the underlying diagnosis and clinical context determine outcomes 1. Patients with hepatitis C can have normal ALT yet progress to cirrhosis, while someone with acute hepatitis A and ALT >1000 U/L typically recovers completely 1.
Why Only ALT May Be Elevated
When ALT rises in isolation without AST, alkaline phosphatase, or bilirubin elevation, this pattern suggests:
- Hepatocellular injury rather than cholestasis (which would elevate alkaline phosphatase and bilirubin) 2
- Early or mild liver disease where other markers haven't yet become abnormal 1
- Metabolic liver disease (NAFLD is the most common cause of isolated mild ALT elevation in Western populations) 1
Immediate Diagnostic Approach
Do not simply repeat the same test—84% of abnormal ALTs remain abnormal at 1 month, and 75% at 2 years 1. Instead, obtain:
Essential History Elements
- Alcohol intake: Quantify in units per week (use AUDIT-C screening)
- Metabolic risk factors: BMI, diabetes, hypertension, dyslipidemia
- Medications: Prescribed, over-the-counter, herbal supplements
- Viral hepatitis risk: Country of origin, injection drug use, sexual history
- Family history: Liver disease, autoimmune conditions, hemochromatosis
- Ethnicity: Affects normal ALT ranges (Asian populations have lower thresholds) 3
Core Laboratory Panel (Order Immediately)
Per guideline recommendations 1:
- Hepatitis B surface antigen (HBsAg)
- Hepatitis C antibody (then PCR if positive)
- Ferritin and transferrin saturation (for hemochromatosis)
- Immunoglobulin G and autoantibodies (ANA, SMA, anti-LKM for autoimmune hepatitis)
- Fasting glucose and lipid panel
- Anti-mitochondrial antibody if cholestatic pattern emerges
Critical Context About "Normal" ALT Values
The traditional upper limits of normal (40 U/L for men, 30 U/L for women) are likely too high 1, 4, 3. These ranges were established using populations that included individuals with occult NAFLD. Updated evidence suggests:
Therefore, your patient's ALT of 87 U/L represents approximately 2-3× the true upper limit and warrants full investigation 5.
Most Likely Causes at This Level
In descending order of probability 1, 6:
- NAFLD (30-35%): Especially with obesity, diabetes, or metabolic syndrome
- Alcohol-related liver disease (28-30%): Even with "moderate" reported intake
- Chronic viral hepatitis (HBV/HCV): Can present with minimal elevation
- Drug-induced liver injury: Review all medications including supplements
- Autoimmune hepatitis: Check IgG and autoantibodies
- Hemochromatosis: Elevated ferritin with transferrin saturation >45%
Common Pitfall to Avoid
Do not assume isolated elevated ferritin equals hemochromatosis—elevated ferritin is common in NAFLD, alcohol excess, and other chronic liver diseases (dysmetabolic iron overload syndrome) 1. Hemochromatosis requires transferrin saturation >45% plus genetic testing.
When to Refer to Specialist
Refer if any of the following are present 1:
- Positive viral hepatitis serology (HBsAg or HCV RNA)
- Elevated IgG with positive autoantibodies
- Transferrin saturation >45% with elevated ferritin
- Evidence of chronic liver disease on exam (hepatosplenomegaly, ascites)
- ALT remains elevated >6 months despite addressing reversible causes
- Any elevation in bilirubin or INR suggesting synthetic dysfunction
Prognostic Considerations
Paradoxically, very low ALT levels (<0.5× ULN) in NAFLD patients predict higher all-cause and cardiovascular mortality than elevated ALT 7. This suggests that ALT elevation represents active inflammation that may be more treatable than "burned-out" disease with low enzymes.
Next Steps Summary
- Obtain core laboratory panel immediately (do not wait and retest ALT)
- Quantify metabolic risk factors (BMI, waist circumference, blood pressure, glucose, lipids)
- Calculate precise alcohol intake in standard units per week
- Review all medications and supplements for hepatotoxic agents
- If core panel negative: Address obesity, alcohol, and medications; recheck in 8-12 weeks
- If persistently elevated >6 months with negative workup: Consider liver biopsy to assess fibrosis 2, 6
The key is recognizing that mild ALT elevations frequently represent treatable conditions (NAFLD, alcohol, viral hepatitis) that can progress to cirrhosis if not identified early 1.